Loring Wolcott & Coolidge Fiduciary Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-8
Closed -$5K 731
2020
Q4
$5K Buy
+8
New +$5K ﹤0.01% 695